Rybelsus (semaglutide) 14mg tablets are a once-daily, oral GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes, often alongside diet and exercise. It works by increasing insulin, reducing glucagon, and slowing gastric emptying to manage blood sugar and potentially aid weight loss. It is taken on an empty stomach with a sip of water, 30 minutes before food.
Rybelsus (semaglutide) is an oral GLP-1 receptor agonist tablet indicated to improve blood sugar control in adults with type 2 diabetes, often used when diet and exercise alone are insufficient. This medication works by increasing insulin release in response to high blood sugar, lowering the secretion of glucagon (a hormone that raises blood sugar), and slowing gastric emptying. These actions help to lower blood glucose levels and may also lead to weight reduction. Rybelsus must be taken on an empty stomach with a small amount of plain water at least 30 minutes before consuming any food or other drinks.
Rybelsus (semaglutide) 7mg tablets are a once-daily, oral GLP-1 receptor agonist prescribed to improve glycemic control in adults with type 2 diabetes by stimulating insulin release and lowering glucagon. Taken on an empty stomach 30 minutes before food, it is typically used after a 30-day initiation with 3mg, often resulting in weight loss, though it is not approved for weight management.